Next report date
Report period
H1 2024
EPS estimate
—
Revenue estimate
—
−10.01 MUSD
6.59 M
Om Akari Therapeutics Plc
Sektor
Bransch
VD
Jacques Rachelle Suzanne
Webbplats
Huvudkvarter
Boston
Grundat
2004
FIGI
BBG003PMV495
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
